CONTACTS
SUBJECTS
CBC Lab WBC 12.8 Elevated Blister Big Toe Left Foot VA for Meeting D
2903 -
2903 - ..
2904 - Summary/Objective
2905 -
290501 - Follow up ref SDS D1 0000. ref SDS D2 0000.
290502 -
290503 -
290504 -
290505 -
290506 -
290508 - ..
2906 -
2907 -
2908 - Background
2909 -
290901 - On 131016 1632 submit letter for agenda meeting to review lab results
290902 - scheduled 131017 1000. ref SDS 41 X45G
290904 - ..
290905 - On 140131 0815 ordered another lab - cbc, electrolytes, lipid with NMR
290906 - - from Labcor to get LDL-P. ref SDS 51 X45G
290908 - ..
290909 - On 140201 1159 had full lab with NMR lipid panel drawn at John Muir
290910 - Hospital on Treat, and by Labcorp. ref SDS 52 RP4N
290912 - ..
290913 - On 140203 1147 had partial lab drawn at VA in Martinez. ref SDS 53
290914 - KK9M
290916 - ..
290917 - On 140507 0857 ordered another full lab from Labcorp with NMR lipid
290918 - panel. ref SDS 59 OO5G
290920 - ..
290921 - On 140508 1133 lab blood daw at Labcorp with John Muir Medical Center
290922 - on Treat Blvd in Concord. ref SDS 60 445G
290924 - ..
290925 - On 140514 0950 VA partial lab at Medical Center in San Francisco.
290926 - ref SDS 63 X45G
290928 - ..
290929 - On 140814 1530 VA full lab at Clinic in Martinez. ref SDS 70 X45G
290931 - ..
290932 - On 140827 1422 VA partial lab CBC only at Clinic in Martinez re-check
290933 - elevated WBC. ref SDS 74 X45G
290935 - ..
290936 - On 141020 1025 Labcorp partial lab CBC Electrolytes Urinalysis, but
290937 - mistakenly omitted NMP lipid panel. ref SDS 76 X45G
290939 - ..
290940 - On 141021 1009 Labcorp NMR Lipid panel, ref SDS 78 U45J, and
290941 - Homocyst(e)ine. ref SDS 78 CM6J
290943 - ..
290944 - On 141201 Health Testing Centers Requisition order # 33541,
290945 - ref SDS 82 FK65, for full panel of blood tests at Labcorp, ref SDS 82
290946 - Q94L - which included NMR Lipid panelto test LDL-P. ref SDS 82 2P5J
290948 - ..
290949 - On 141021 1150 VA labs electrolytes, ref SDS 78 ZG5O, and lipids.
290950 - ref SDS 78 U45J
290952 - ..
290953 - On 150208 Health Testing Centers Requisition order # 34764,
290954 - ref SDS 85 IG6J, for full panel of blood tests at Labcorp, ref SDS 85
290955 - Q94L, which included NMR Lipid panelto test LDL-P. ref SDS 85 2P5J
290957 - ..
290958 - On 150512 0703 Health Testing Centers Requisition order # 36923,
290959 - ref SDS 89 8S7F, for full panel of blood tests at Labcorp, ref SDS 89
290960 - Q94L, which included NMR Lipid panelto test LDL-P. ref SDS 89 2P5J
290962 - ..
290963 - On 150512 1239 blood draw at Labcorp for NMR lipids. ref SDS 90 FK6I
290965 - ..
290966 - On 150512 1330 blood draw at VA in Martinez. ref SDS 91 X45G
290968 - ..
290969 - On 150723 2232 Health Testing Centers Requisition order # 38564 that
290970 - was not used, ref SDS 93 8S7F, for full panel of blood tests at
290971 - Labcorp, ref SDS 93 Q94L, which included NMR Lipid panel to test
290972 - LDL-P. ref SDS 93 2P5J
290974 - ..
290975 - 160131 0500 Labcorp lab using prior order # 461850, because it does
290976 - not expire until 160423. ref SDS A3 RH5L
290977 -
290978 -
290979 -
290980 -
290981 -
290982 -
290983 -
290985 - ..
2910 -
2911 -
2912 - Progress
2913 -
291301 - See directory structure for medical records on 140320 1125.
291302 - ref SDS 57 4M5I
291304 - ..
291305 - This follows up lab at VA ordered by Karen on 170412 0700. ref SDS C7
291306 - T16O
291308 - ..
291309 - This follows up lab performed at San Joaquin General Hospital in
291310 - French Camp, California, South of Stockton, reported in another record
291311 - on 170905 2230, ref SDS C9 RR7H, and to evaluate for injuries from
291312 - automobile accident an hour earlier, reported in another record on
291313 - 170905 2230. ref SDS C9 KO5H Lab performed 4 hours later showed WBC
291314 - 24.4 on 170906 0420. ref SDS D1 LY7F Glucose 158 was also reported.
291315 - ref SDS D1 ZG5O
291317 - ..
291318 - Lab today ordered by Lauren in Primary Care reported on 170911 1000.
291319 - ref SDS D3 G54F
291321 - ..
291322 - Tech drawing blood today, reported blood looks excellent, reflecting
291323 - INR 1.1 lab at San Joaquin General on 170905 2350. ref SDS D0 2B4N
291324 - This seems to resolve concern that blood is too thick, and so requires
291325 - taking Aspirin, presented by Doctor Tucker on 170726 1600. ref SDS C8
291326 - TZ99
291327 -
291328 -
291330 - ..
291331 - Lab CBC Evaluate Health 8 Years After CABG x4 Heart Surgery
291332 - WBC 11 Elevated Aligns Trauma Automobile Accident Collision 65 MPH
291333 -
291334 - Follow up ref SDS D1 RP4N, ref SDS D2 RP4N.
291335 -
291336 - Prior VA CBC on 120509 1108. ref SDS 26 RP4N
291337 - Prior VA CBC on 120831 1524. ref SDS 27 RP4N
291338 - Prior VA CBC on 121130 1001. ref SDS 31 RP4N
291339 - Prior VA CBC on 130529 0818. ref SDS 38 RP4N
291340 - Prior Labcorp CBC on 140201 1159. ref SDS 52 RP4N
291341 - VA did not order CBC for lab on 140203 1147. ref SDS 53 YX8K
291342 - Prior Labcorp CBC on 140508 1149. ref SDS 60 RP4N
291343 - VA did not order CBC for lab on 140514 0950. ref SDS 63 RP4N
291344 - Prior VA CBC on 140814 1530. ref SDS 70 RP4N
291345 - Prior VA CBC on 140827 1413. ref SDS 74 RP4N
291346 - Prior Labcorp CBC on 141020 1025. ref SDS 76 RP4N
291347 - Prior Labcorp CBC on 141201 0850. ref SDS 83 RP4N
291348 - Prior Labcorp CBC on 150208 1438. ref SDS 86 RP4N
291349 - Prior Labcorp CBC on 150512 1239. ref SDS 90 RP4N
291350 - Prior VA CBC on 150512 1349. ref SDS 91 RP4N
291351 - Prior VA CBC on 150728 1146. ref SDS 94 RP4N
291352 - Prior Labcorp CBC on 160131 1700. ref SDS A3 RP4N
291353 - Prior Labcorp CBC on 160401 1219. ref SDS A6 RP4N
291354 - Prior Labcorp CBC on 160717 1053. ref SDS B3 RP4N
291355 - Prior Labcorp CBC on 161009 1320. ref SDS B4 RP4N
291356 - Prior VA CBC on 161011 1100. ref SDS B5 RP4N
291357 - Prior Labcorp CBC on 170215 1634. ref SDS C1 RP4N
291358 - Prior VA CBC on 170412 0700. ref SDS C7 RP4N
291359 - Prior San Joaquin General Hospital on 170905 2350. ref SDS D0 RP4N
291360 - Prior San Joaquin General Hospital on 170906 0420. ref SDS D1 RP4N
291361 - Prior VA CBC on 170911 1047. ref SDS 0 RP4N
291363 - ..
291364 - Blood draw in Laboratory Department...
291365 -
291367 - ..
291368 - CBC PANEL
291369 - x
291370 - Dates......... 2017 09 11 1047 170906 0420 170905 2350 170412 0702 160206 1639 161011 1114 161009 1337 160717 1055 160401 1443 160202 1334 160131 1714 150728 1154 150512 1349 150512 1300 150208 141201 141020 140827 140814 140514 140508 140203 140201 130529
291371 - VAMCSF San Joaquin Gnrl Joaquin Gnrl VAMCSF Labcorp VAMCSF Labcorp Labcorp Labcorp VA Labcorp VA VA Labcorp Labcorp Labcorp Labcorp VA VA VA Labcorp VA Labcorp VA VA Labcorp
291372 - Blood Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Units Range Range
291373 - WBC LEUKOCYTES 11.0 H 24.4 H 11.9 H 9.5 12.3 H 13.9 H 14.6 H 8.4 8.9 9.4 11.3 H 7.4 8.9 7.6 10.6 11.2 H 13.3 H 13.8 H 12.8 H 9.5 6.2 7.4 K/cmm 4.8 - 10.8 3.4 - 10.8
291374 - RBC ERYTHROCYTES 5.17 5.18 5.42 5.28 5.7 5.32 5.2 5.3 5.60 5.51 5.41 5.10 5.15 5.15 5.46 5.24 5.64 5.56 5.44 5.21 5.13 5.09 M/cmm 4.7 - 6.1 4.14 - 5.80
291375 - HGB Hemoglobin 14.7 14.7 15.6 15.4 17.1 15.2 15.4 15.7 16.3 15.3 15.2 15.3 15.3 15.1 16.2 15.7 16.5 16.4 16.2 15.1 15.2 15.0 g/dL 14 - 18 12.6 - 17.7
291376 - HCT Hematocrit 44.6 44.9 47.2 46.1 51.2 H 47.5 46.6 48.7 48.6 47.6 46.0 46.0 46.3 45.5 47.7 47.4 50.1 48.8 48.3 47.0 44.2 46.2 % 42 - 52 37.5 - 51.0
291377 - MCV 86.3 86.7 87.0 87.3 89 89.3 90 92 87.0 86.4 85 90.3 89.8 88.0 87.0 91.0 89.0 87.8 88.7 90.0 86.0 90.7 fL 80 - 99 79.0 - 97.0
291378 - MCH 28.4 28.4 28.7 29.2 29.8 28.6 29.6 29.6 29.1 27.7 28.1 29.9 29.8 29.3 29.7 30.0 29.3 29.5 29.8 29.0 29.6 29.5 uug 27 - 34 26.6 - 33.0
291379 - MCHC 33.0 32.8 33.0 22.4 33.4 32 0 33 0 32 2 33.5 32.1 33.0 33.2 33.1 33.2 34.0 33.1 32.9 33.6 33.6 32.1 34.4 32.5 gm/dL 32 - 35.2 31.5 - 35.7
291380 - RDW ERYTHROCYTE D W 13.7 14.3 13.9 13.9 14.1 14 5 15.2 13.8 13.6 13.6 13.9 14.3 13.9 13.9 13.8 13.7 14.4 % 11.5 - 14.5 12.3 - 15.4
291381 - PLT 370 300 338 323 385 H 385 434 H 319 335 325 348 294 315 326.0 321.0 314.0 341.0 322.0 295.0 329 303 279 K/cmm 130 - 400 155.0 - 379.0
291382 - MPV 8.2 8.9 8.9 9.1 8.3 8.8 fL 7 - 10.4
291383 - NEUT % 90 H 95.4 H 78 83 75 73 79 76.3 74.0 76.0 82.0 80.0 74.2 78.1 70 69 69.9 % 40 - 80 40.0 - 74.0
291384 - BAND NEUT 0
291385 - LYMPH % 1.4 3.9 L 11 11 16 16 14 16.5 L 19.0 15.0 12.0 13.0 14.9 L 13.6 L 20 21 L 19.7 % 20 - 51 14.0 - 46.0
291386 - MONO % 6.0 0.6 L 8 6 6 8 6 6.0 6.0 7.0 5.0 7.0 9.8 7.6 8 8 7.8 % 2 - 13 4.0 - 12.0
291387 - EOS % 0 0.0 1 0 2 2 0 0.6 1.0 1.0 1.0 0.0 0.3 L 0.4 L 1 1 1.9 % .5 - 7 0.0 - 5.0
291388 - BASO % 0 0.1 1 0 1 1 1 0.6 0.0 1.0 0.0 0.9 0.8 0.3 1 1 0.7 % 0 - 2 0.0 - 3.0
291389 - NEUT # 8.36 11.40 H 9.9 H 12.1 H 6.3 6.5 9.0 H 6.6 5.5 8.2 H 9.1 H 10.5 H 10.3 H 10.0 H 6.7 4.3 5.2 K/cmm 1.5 - 7.9 1.4 - 7.0
291390 - LYMPH # 1.32 0.50 L 1.3 1.6 1.4 1.4 1.6 1.4 1.5 1.6 1.4 1.7 2.1 1.7 1.9 1.3 1.5 K/cmm 1.2 - 3.4 0.7 - 3.1
291391 - MONO # 0.94 0.10 L 0.9 0.9 0.5 0.7 0.7 0.5 0.5 0.7 0.6 0.9 1.3 H 1.0 0.7 0.5 0.6 K/cmm .2 - 1.2 0.1 - 0.9
291392 - EOS # 0.15 0.00 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.9 L 0.1 0.1 0.1 0.1 K/cmm .1 - .5 0.0 - 0.4
291393 - BASO # 0.09 0.00 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 K/cmm 0 - .2 0.0 - 0.2
291394 - ESRmVES mm/hr 0 - 10
291395 - ESRxCYT mm/hr 2 - 10
291396 - RETIC % % .66 - 2.85
291397 - RETIC # k/uL 27.9 - 121.6
291398 - Immature Granulocytes 1 0 0 0,0 0,0 0,0 0.0 0.0 0.0 0.0 0.0 0.0 % 0.0 - 2.0
291399 - Immature Grans (Abs) 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 % 0.0 - 0.1
291400 - NRBC 0.0 0.2 0 % 0 - 0
291401 - ANIOCYTOSIS # 1+
291402 - PLATELET ESTIMATE ADEQUATE
291403 -
291404 -
291405 -
291406 -
291407 -
291408 -
291409 -
291410 -
291411 -
291412 -
2915 -
SUBJECTS
Urinalysis Lab VA No Results
4403 -
440401 - ..
440402 - Urinalysis Ketones Trace Abnormal Sp Gravity Above Range
440403 -
440404 - Follow up ref SDS D1 0X72, ref SDS D2 0X72.
440405 -
440406 - Prior Urinalysis test on 101207 0906. ref SDS 15 0X72
440407 - Prior Urinalysis test on 120509 1108. ref SDS 26 0X72
440408 - Prior Urinalysis test on 140201 1159. ref SDS 52 0X72
440409 - VA did not order urinalysis for lab on 140203 1147. ref SDS 53 0X72
440410 - Prior Urinalysis Labcorp test on 140508 1149. ref SDS 60 0X72
440411 - Prior Urinalysis test on 140814 1530. ref SDS 70 0X72
440412 - Prior Urinalysis Labcorp test on 141020 1025. ref SDS 75 0X72
440413 - Prior Urinalysis Labcorp test on 141201 0850. ref SDS 82 0X72
440414 - Prior Urinalysis Labcorp test on 150208 1438. ref SDS 85 0X72
440415 - Prior Urinalysis Labcorp test on 150512 1239. ref SDS 89 0X72
440416 - Prior Urinalysis Labcorp test on 160131 1700. ref SDS A2 0X72
440417 - Prior Urinalysis Labcorp test on 160401 1219. ref SDS A6 0X72
440418 - Prior Urinalysis Labcorp test on 160717 1053. ref SDS B3 0X72
440419 - Prior Urinalysis Labcorp test on 161009 1320. ref SDS B4 0X72
440420 - Prior Urinalysis Labcorp test on 170216 1634. ref SDS C1 0X72
440421 - Prior Urnialysis San Joaquin General test on 170906 0040, ref SDS D2 0X72
440422 -
440424 - ..
440425 - URINALYSIS PANEL
440426 - x
440427 - Dates..........2017 09 06 0040 02 16 1639 161009 1337 160717 1055 160401 1443 16011 1714 150512 1300 150208 141201 141020 140814 140514 140203 140201 120509
440428 - San Joaquin General Labcorp Labcorp Labcorp Labcorp Labcorp Labcorp Labcorp Labcorp Labcorp VA VA Labcorp VA Labcorp VA VA Labcorp
440429 - Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Units Range Range
440430 - PH 6.5 5.5 5.5 7.5 7.5 6.0 7.0 6.0 5.5 6.0 6.0 5.5 5.5 6.0 5 - 9 5.0 - 7.5
440431 - PROTEIN NEG Trace NEG NEG Trace NEG NEG NEG Trace Trace NEG NEG NEG NEG mg/dL NEG - TRACE NEG - TRACE
440432 - GLUCOSE Trace NEG NEG NEG NEG NEG NEG NEG NEG NEG NEG NEG NEG NEG mg/dL Ref: NEG NEG
440433 - KETONES Trace Trace Abnormal NEG NEG NEG 2+ Abnormal NEG 1+ Abnormal 1+ Abnormal Trace Abnormal 15 Trace Abnormal NEG NEG mg/dL Ref: NEG NEG
440434 - BILI NEG NEG NEG NEG NEG NEG NEG NEG NEG NEG NEG NEG NEG NEG Ref: NEG NEG
440435 - BILIcnf Ref: NEG
440436 - BLOOD 1+ TRACE TRACE TRACE TRACE Ref: NEG
440437 - NITRITE, URINE NEG NEG NEG NEG NEG NEG NEG NEG NEG NEG NEG NEG NEG Ref: NEG NEG
440438 - UROBILI 0.2 0.2 0.2 0.2 0.2 0.2 ?? 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 EU/dL .2 - 1 0.0 - 1.9
440439 - LEU EST NEG NEG Ref: NEG
440440 - SP.GRAV >1.030 H 1.030 1.028 1.018 1.020 1.029 1.018 1.028 1.035 H 1.030 >=1.030 H 1.036 1.026 1.025 1.003- 1.035 1.005 - 1.030
440441 - COLOR YELLOW YELLOW YELLOW YELLOW YELLOW YELLOW YELLOW YELLOW YELLOW YELLOW YELLOW YELLOW YELLOW YELLOW
440442 - APPEAR CLEAR Cloudy Abnormal CLEAR CLEAR CLOUDY ABNORMAL CLEAR CLEAR CLEAR CLEAR CLEAR CLEAR CLEAR CLEAR CLEAR
440443 - WBC 0-5 0-5 0-5 /hpf 0 - 5
440444 - WBC ESTERASE NEG NEG NEG NEG NEG NEG NEG NEG NEG NEG NEG
440445 - RBC 0-5 0-2 0-2 /hpf 0 - 2
440446 - OCCULT BLOOD NEG NEG NEG NEG Trace Abnormal NEG NEG NEG NEG NEG NEG NEG
440447 - HAYALINE CASTS NONE NORM(0-1) per lpf 0 - 1
440448 - GRANULAR CASTS None per lpf Ref: None
440449 - CELLULAR CASTS None per lpf Ref: None
440450 - RBC/HPF NORM(0-3) per lpf 0 - 3
440451 - BACTERIA NONE None seen None seen 0 - 1 None seen / Few
440452 - EPITHELIAL CELLS FEW None seen 0-10 NORM(0-1) /hpf 0 - 10
440453 - RENAL EPITHELIAL CELLS None per lpf Ref: None
440454 - CALCIUM OXILATE CRYST Present Abnormal N/A
440455 - URIC ACID CRYSTALS NORM(0-1) per lpf 0 - 1
440456 - TRIPLE PHOSPHATE CRYST NORM(0-1) per lpf 0 - 1
440457 - AMORPHOUS SEDIMENT None per lpf Ref: None
440458 - MUCOUS Present No Report Present Present Not Established
440459 - TRICHOMONAS None per lpf Ref: None
440460 - YEAST None per lpf Ref: None
440461 - CULTURE REFLEXED No
440462 - TR EPTH None per lpf Ref: None
440463 - NITRITE, URINE NEG NEG NEG NEG
440464 - Microscopic Examination
440465 - Microscopic follows if indicatlows if indicated
440466 - ALBUMIN
440467 - ALBUMIN/creatinine
440468 - CREATININE
440469 -
440471 - ..
440472 - URINE TOX SCREEN
440473 - ..
440474 - x
440475 - Dates..........2017 09 06 0040
440476 - San Joaquin General
440477 - Results
440478 - BARBITURATE NEG
440479 - BENZODIAZEPINE POS cut off rate 200 ng/ml
440480 - OPIATE NEG
440481 - CANNABINOID NEG
440482 - AMPHETAMINE NEG
440483 - COCAINE NEG
440484 - PCP SCREEN NEG
440485 - URINE METHADONE NEG
440486 -
440487 -
440488 -
440489 -
440490 -
440491 -
440492 -
4405 -
SUBJECTS
Lab Electrolytes Chem Profile Glucose 97 Sodium NA 144 Potasium K 5.
6103 -
610401 - ..
610402 - T Bili 2.0 Hyperbilirubinemia Worsens Resuming Atorvastatin Ezetimibe
610403 - Potasium K 5.1 Decreased Electrical Problems Heart
610404 - Bun/Creatinine Ratio Elevated Slightly
610405 - LDH Elevated and Electrolytes May Correlate Increased Endurance Exercise
610406 -
610407 - Follow up ref SDS D1 KK9M, ref SDS D2 KK9M.
610408 -
610409 - Prior CHEM PROFILE on 120509 1108. ref SDS 26 KK9M
610410 - Prior CHEM PROFILE on 120831 1524. ref SDS 27 KK9M
610411 - Prior CHEM PROFILE on 130228 1140. ref SDS 36 KK9M
610412 - Prior CHEM PROFILE on 130529 0818. ref SDS 38 KK9M
610413 - Prior CHEM PROFILE on 131015 0724. ref SDS 40 KK9M
610414 - Prior CHEM PROFILE Labcorp on 140201 1159. ref SDS 52 KK9M
610415 - Prior CHEM PROFILE on 140203 1147. ref SDS 53 KK9M
610416 - Prior CHEM PROFILE Labcorp on 140508 1149. ref SDS 60 KK9M
610417 - Prior CHEM PROFILE on 140520 0732. ref SDS 66 KK9M
610418 - Prior CHEM PROFILE on 140814 1530. ref SDS 70 KK9M
610419 - Prior CHEM PROFILE Labcorp on 141020 1025. ref SDS 75 KK9M
610420 - Prior CHEM PROFILE on 141021 11150 ref SDS 77 KK9M
610421 - Prior CHEM PROFILE Labcorp on 141201 0840. ref SDS 82 KK9M
610422 - Prior CHEM PROFILE Labcorp on 150208 1438. ref SDS 84 KK9M
610423 - Prior CHEM PROFILE Labcorp on 150208 14380 ref SDS 85 KK9M
610424 - Prior CHEM PROFILE on 150209 10120 ref SDS 86 KK9M
610425 - Prior CHEM PROFILE Labcorp on 150512 1239, ref SDS 89 KK9M
610426 - Prior CHEM PROFILE on 150728 11146, ref SDS 93 KK9M
610427 - Prior CHEM PROFILE Labcorp on 160131 1700, ref SDS A2 KK9M
610428 - Prior CHEM PROFILE on 160202 1220. ref SDS A4 KK9M
610429 - Prior CHEM PROFILE Labcorp on 160401 1219, ref SDS A6 KK9M
610430 - Prior CHEM PROFILE at VA on 160503 1130. ref SDS A7 KK9M
610431 - Prior CHEM PROFILE Labcorp on 160717 1053. ref SDS B3 KK9M
610432 - Prior CHEM PROFILE Labcorp on 161009 1320. ref SDS B4 KK9M
610433 - Prior CHEM PROFILE Labcorp on 170216 1534. ref SDS C1 KK9M
610434 - Prior CHEM PROFILE at VA on 170412 0700. ref SDS C7 KK9M
610435 -
610437 - ..
610438 - ELECTROLYTES - CHEM PROFILE
610439 - BASIC METABOLIC
610440 -
610441 - ..
610442 - x
610443 - Dates.........2017 09 11 1047 170906 0420 170905 2350 170412 0700 02 16 1639 161011 1114 161009 1337 160717 1055 160503 1145 160401 1443 160202 1334 160131 1714 150728 1154 150512 1349 150512 1300 150209 150208 141201 141021 141020 140814 140520 140514 140508 140203 140201 131015 130529
610444 - VAMCSF San Joaquin Gnrl San Joaquin Gnrl VAMCSF Labcorp VAMCSF Labcorp Labcorp VA Labcorp VA Labcorp VA VA Labcorp VA Labcorp Labcorp VA Labcorp VA VA VA Labcorp VA Labcorp VA VA VA Labcorp
610445 - PLASMA Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Units Range Range
610446 - GLUCOSE 114 158 H 179 H 110 92 109 96 108 H 104 112 H 104 87 110 104 99 108 89 104 H 110 H 105 98 98 97 103 98 108 H 120 mg/dL 74 - 118 65.0 - 99.0
610447 - GLUfast mg/dL Ref: <=99
610448 - NA (salt) 142 135 134 L 142 149 H 144 144 145 H 141 148 H 144 147 H 142 138 141 145 144 147 H 138 144 144 139 144 140 140 139 139 mmol/L 136 - 144 134.0 - 144.0
610449 - K (potassium) 4.4 4.3 4.2 4.4 5.1 6.0 H 5.5 H 5.7 H 4.8 5.3 H 5.0 H 5.3 H 4.4 4.4 5.0 5.5 H 5.3 H 5.6 H 4.4 4.3 4.3 H 5.2 H 5.6 H 5.4 4.8 4.3 H 4.9 mmol/L 3.4 - 4.8 3.5 - 5.2
610450 - CL 105 104 103 104 105 107 103 103 103 102 108 106 104 100 99 109 103 106 103 H 108 H 108 102 105 103 102 105 105 mmol/L 98 - 106 97.0 - 108.0
610451 - CO2 39 22 L 20 L 31 21 28 23 25 27 27 27 31 31 30 29 28 29 29 29.0 30.0 37.0 30.0 mmol/L 23 - 33
610452 - AGAP 8.0 13.3 15.2 7.0 9.0 11.0 11.0 9.0 9.0 7.0 7.0 7.0 7.0 8.0 mmol/L 5 - 20
610453 - BUN 18 21 23 20 26 37 H 28 H 17 34 H 21 24 22 22 17 29 H 26 H 28 H mg/dL 8 - 26 8.0 - 27.0
610454 - * BUN/Creati Ratio 25 26 H 20 20 18 26 H 24 H 22 H 28 19 H 23 17 20 24 18 10.0 - 22.0
610455 - CREAT 0.9 0.85 0.94 1.0 1.22 1.1 1.09 1.01 1.2 1.06 1.1 1.09 1.0 0.80 0.96 0.9 0.99 1.16 0.8 1.13 1.03 0.80 0.97 0.82 0.81 0.83 0.83 mg/dL .5 - 1.1 0.76 - 1.27
610456 - eGFR INA 82 >60 >60 73 59 L 65 68 74 61 70 64 68 72 80 80 77 64 91 66 >60 102 79 >60 91 >60 >60 mL/min Ref: >=60 >59
610457 - eGFR IA 79 86 81 79 92 89 74 76 92 106 mL/min >59
610458 - CALCIUM 9.6 8.9 9.1 9.3 10.4 H 9.6 10.0 9.7 9.1 9.5 9.1 9.8 9.2 9.1 9.5 9.6 10.0 10.0 8.8 9.9 9.1 8.9 9.5 9.3 9.4 9.2 9.2 mg/dL 8.7 - 10.2 8.6 - 10.2
610459 - CA CORR mg/dL 8.7 - 10.2
610460 - PO4 mg/dL 2.4 - 4.5
610461 - MG 85 mg/dL 1.8 - 2.5
610462 - ALK PHO 98 104 90 105 108 82 82 82 100 79 79 88 98 96 107 85 86 100 105 84 87 U/L 37 - 107 39.0 - 117.0
610463 - Phosphorous, Serum 4.1 3.2 3.4 2.9 3.2 mg/dL 2.5 - 4.5
610465 - ..
610466 - T. BIL 1.4 H 2.0 H 1.7 H 1.3 1.0 1.8 H 2.2 H 1.7 H 1.6 1.2 1.5 H 1.9 H H 2.0 H 2.5 1.2 H 2.2 H 1.3 H 2.1 H 1.6 H 1.7 H 1.3 mg/dL .1 - 1.2 0.0 - 1.2
610467 - D. BILI 0.1 0.28 0.20 0.34 0.23 0.31 0.38 0.38 0.3 0.2 0.2 0.32 0.3 0.34 < 0.1 mg/dL .1 - .4 0.00 - 0.40
610468 - Bilirubin, Indir 1.52 H 1.36 H 0.97 H 1.19 H 1.52 H H 1.62 0.98 1.26 H mg/dL 0.10 - 0.80
610469 - AST (SGOT) 70 H 26 27 24 21 24 33 26 17 23 26 31 25 23 26 23 21 20 22 IntUnits/L 8 - 42 0.0 - 40.0
610470 - ALT (SGPT) 57 H 22 25 23 22 32 22 22 17 18 23 30 21 21 17 21 19 17 19 IntUnits/L 5 - 55 0.0 - 44.0
610471 - ALBUMIN 4.0 4.8 4.3 4.4 4.3 4.5 4.3 4.5 4.2 4.2 4.5 4.5 4.8 4.7 4.8 4.3 3.9 4.6 4.6 4.1 4.4 3.9 4.0 g/dL 3.3 - 5.2 3.6 - 4.8
610472 - PROTEIN (TP) 7.0 7.1 7.0 6.7 6.5 7.0 6.7 7.0 7.0 6.5 6.9 6.6 6.9 7.2 6.5 7.5 6.6 6.7 6.5 7.1 7.2 g/dL 6.0 - 8.5 6.0 - 8.5
610473 - Globulin, Total 3.0 2.3 2.3 2.2 2.5 2.2 2.1 1.9 2.1 2.0 2.1 g/dL 1.4 - 4.5
610474 - A/G Ratio 1.3 2.1 1.9 2.0 1.8 2.0 2.3 2.5 2.3 2.3 2.1 1.1 - 2.5
610475 - LDH 193 268 H 189 240 H 241 H 223 200.0 180.0 IntUnits/L 90 - 208 0.0 - 225.0
610476 - GGT 14 11 13 13 11.0 9.0 IU/L 0.0 - 65.0
610477 - Iron, Serum 98 110 115 89 101 146 100.0 114.0 ug/dL 40.0 - 155.0
610478 - AMYLASE Units/L 28 - 100
610479 - LIPASE Units/L 7 - 58
610480 - NH3 mcmol/L 15 - 56
610481 - URIC AC 5.4 5.3 4.9 5.4 mg/dL 4.8 - 8.7 3.7 - 8.6
610482 - * ALANINE AMINOTR 20 IntUnits/L 5 - 55
610483 - * ASPARTATE AMINOTR 23 IntUnits/L 8 - 42
610484 - GLOMERULAR FILTRATION
610485 - RATE.PREDICTED 95.6 mL/min > 60
610486 - * UREA NITROGEN 18 mg/dL 8 - 26
610488 - ..
610489 - Cholesterol, Total 197 179 284 H 167 161 174 164.0 162.0 mg/dL 100.0 - 199.0
610490 - Triglycerides 83 64 107 60 66 79 55.0 64.0 mg/dL 0.0 - 149.0
610491 - HDL Cholesterol 53 73 57 68 67 61 > 39
610492 - LDL Cholesterol 127 93 206 H 87 81 96 0 - 99
610493 - T Chol/HDL ratio 3.7 2.5 5.0 2.5 2.4 2.8 0.0 - 5.0
610494 -
610495 - TG/HDL ratio...... . 1.57 0.88
610497 - ..
610498 - These Labcorp lab numbers on 160401 align with NMR lipid report below.
610499 - ref SDS A2 5C7M
610501 - ..
610502 - Labcorp lab report continues...
610503 -
610504 - Please Note:
610505 -
610506 - T Chol/HDL Ratio Men Women
610507 -
610508 - 1/2 Avg Risk 3.4 3.3
610509 - Avg Risk 5.0 4.4
610510 - 2x Avg Risk 9.6 7.1
610511 - 3x Avg Risk 23.4 11.0
610513 - ..
610514 - Estimated CHD Risk < 0.5 times avg 0.0 - 1.0
610515 -
610517 - ..
610518 - The CHD Risk is based on the T Chol/HDL ratio.
610519 - Other factors affect CHD Risk such as hypertension,
610520 - smoking, diabetes, severe obesity, and family history
610521 - of premature CHD.
610522 -
610524 - ..
610525 - a. Test Performed at...
610526 - Jenny Galloway, MD
610527 - LabCorp San Diego
610528 - 13112 Evening Creek Dr So Ste 200, San Diego, CA 92128-4108
610530 - ..
610531 - For inquiries, the physician may contact Branch:
610532 - 800-762-4344 Lab: 858-668-3700
610533 -
610534 -
610535 -
610537 - ..
610538 - Notes on Electrolytes Lab Hyperbilirubinemia Potassium Heart Problems
610539 - Hyperbilirubinemia Potassium Heart Problems Notes on Electrolytes Lab
610540 - Potassium Heart Problems Hyperbilirubinemia Notes on Electrolytes Lab
610541 -
610542 - Follow up ref SDS D1 G34G, ref SDS D2 G34G.
610543 -
610544 - For some reason, T Bilirubin was not checked this cycle by the VA...
610545 -
610546 - 1. T Bilirubin ...0.3 - 1.2..... ref SDS A7 015M
610548 - ..
610549 - Collection DT T Bili Range Source
610550 - 05/03/2016 11:45 ...0.3 - 1.2.. ref SDS A7 015M
610551 - 04/01/2016 14:43 1.8 H...0.3 - 1.2.. ref SDS A6 015M
610552 - 02/02/2016 13:34 2.2 H...0.3 - 1.2.. ref SDS A4 015M
610553 - 01/31/2016 17:14 1.7 H...0.3 - 1.2.. ref SDS A3 015M
610554 - 05/12/2015 13:49 1.6 H...0.3 - 1.2.. ref SDS 90 015M
610555 - 05/12/2015 13:00 1.2 ...0.3 - 1.2.. ref SDS 89 015M
610556 - 02/08/2015 14:52 1.5 H...0.3 - 1.2.. ref SDS 85 015M
610557 - 01/12/2014 08:40 1.9 H...0.3 - 1.2.. ref SDS 82 015M
610558 - 20/10/2014 10:60 2.0 H...0.3 - 1.2.. ref SDS 75 015M
610559 - 14/08/2014 15:28 2.5 H...0.3 - 1.2.. ref SDS 70 WJ5H
610560 - 20/05/2014 10:20 1.2 ....0.3 - 1.2.. ref SDS 66 015M
610561 - 08/05/2014 11:49 1.3 H...0.0 - 1.2.. ref SDS 60 015M
610562 - 03/02/2014 09:52 2.1 H...0.3 - 1.2.. ref SDS 53 015M
610563 - 01/02/2014 12:28 1.6 H...0.0 - 1.2.. ref SDS 52 015M
610564 - 15/10/2013 08:25 1.7 H...0.3 - 1.2.. ref SDS 40 015M
610565 - 29/05/2013 08:18 1.3 H...0.3 - 1.2.. ref SDS 38 1Y9G
610566 - 28/02/2013 08:36 1.3 H...0.3 - 1.2.. ref SDS 36 6S4F
610567 - 31/08/2012 15:24 2.3 H...0.3 - 1.2.. ref SDS 27 NV9M
610568 - 09/05/2012 11:24 2.5 H...0.3 - 1.2.. ref SDS 26 O46K
610569 - 09/02/2012 11:18 1.8 H...0.3 - 1.2.. ref SDS 22 KK9M
610570 - 17/11/2011 14:27 1.3 H.............. ref SDS 20 KK9M
610571 - 13/10/2011 14:35 1.3 H.............. ref SDS 19 GM65
610572 - 27/07/2011 12:58 2.0 H.............. ref SDS 16 GM65
610573 - 07/12/2010 09:17 1.0 ............... ref SDS 15 GM65
610574 - 21/07/2010 08:54 1.3 H.............. ref SDS 11 GM65
610575 - 14/12/2009 1.3 H ............. ref DRP 1 DE4O
610576 - 02/11/2009 0.9 ............... ref DRP 1 LG4L
610577 - 13/08/2009 15:09 1.7 H.............. ref SDS 5 VG8R
610579 - ..
610580 - On 131017 1000 VA medical chart Progress Notes assessment
610581 - reports Doctor Egan diagnosed chronic hyperbilirubinemia.
610582 - ref SDS 42 PSXT
610584 - ..
610585 - T Bilirubin 1.7 elevated slightly above range shows increase
610586 - from 1.6 in prior lab on 150512, and maintaining dramatic
610587 - decline from Bilirubin 2.5 reported for lab at VA Martinez
610588 - Clinic performed on 140814 1530. ref SDS 70 015M This latest
610589 - result for T Bili in patient history, may demonstrate chronic
610590 - side effects statin medications causing poor liver function, as
610591 - reviewed previously on prior lab on 140514 0950. ref SDS 63
610592 - G34G Side effects of peripheral neuropathy in right foot have
610593 - ebbed and flowed, reported on 140510, shown in case study on
610594 - 120101 0900. ref SDS 21 TV6I
610596 - ..
610597 - On 160131 1700 elevated LDH may also indicate liver damage due
610598 - to statin medication. at ref SDS A2 NS5N
610600 - ..
610601 - On 140819 0800 during meeting with Doctor Sandhu in Primary
610602 - Care VA Clinic in Martinez, there was no review of chronic
610603 - hyperbilirubinemia, with T Bilirubin 2.5 rising 110% above
610604 - range, ref SDS 72 9K7I, shown in lab ordered by the doctor on
610605 - 140814. ref SDS 70 015M
610607 - ..
610608 - Background on Rosuvastatin causing elevated T Bilirubin with
610609 - associated severe side effects is reported on 121206 0900,
610610 - ref SDS 32 NI9L, and further explained in the record on 121130
610611 - 0846. ref SDS 31 ER4K
610613 - ..
610614 - On 131017 1000 Doctor Egan explained patient history of
610615 - intermittant and mild peripheral neuropathy that correlates
610616 - with persistent elevated T Bilirubin in lab on 131015,
610617 - ref SDS 40 015M, and further reported with vitals, diet and
610618 - exercise since prior meeting at VA on 130603, see case study on
610619 - 120101 0900, ref SDS 21 X14N, suggests intervention is not
610620 - required at this time to improve recovery from side effects
610621 - taking Rosuvastatin. ref SDS 42 LV5J
610622 -
610624 - ..
610625 - 2. Potassium K 5.0 ............................. ref SDS A6 ZG5O
610626 -
610627 - Potassium 5.3 increased above range, and above prior test 4.4
610628 - on 150512, ref SDS 90 WJ5H; may reflect increased hiking 240
610629 - miles past 3 weeks. see history of hiking mileage below.
610630 - ref SDS A2 GY6H
610632 - ..
610633 - Similarly, dramatic decline in hiking for 6 weeks from June to
610634 - August last year (see again hiking history below, ref SDS 86
610635 - ZY7M), and reported on the agenda for meeting with Doctor
610636 - Sandhu in Primary Care, which was submitted on 140814 2227.
610637 - ref SDS 71 K098, may correlate with potassium falling back
610638 - within range, at that time. This record shows correlation
610639 - between elevated Potassium and extended endurance hiking.
610641 - ..
610642 - Doctor Egan, referring cardiology physician at Martinez VA,
610643 - noted in a letter that meeting at VA Medical Center in San
610644 - Francisco on 140213 0830, ref SDS 56 GT7G, did not address
610645 - elevated potassium in labs performed by Labcorp and VA, shown
610646 - on 140203 1147. ref SDS 53 ZG5O Doctor Egan again notified
610647 - that this condition of elevated potassium represents exposure
610648 - to "electrical problems" with the heart, reported on 140430.
610649 - ref SDS 58 UV5I
610651 - ..
610652 - Doctor Egan was concerned last year about potassium (K) rising
610653 - above range for good health. He explained potassium effects
610654 - electrical signals to the heart, and so has significance for
610655 - CVD, reported during meeting at VA on 121206 0900. ref SDS 32
610656 - 6K56
610658 - ..
610659 - At that time on 121206, the doctor cited medication conflicts
610660 - as possibly causing elevated potassium. ref SDS 32 FI7L Doctor
610661 - Egan further considered dehydration (urination) caused by
610662 - Rosuvastatin may have skewed lab results for electrolytes on
610663 - 121130, and so ordered re-test. ref SDS 32 6K4J
610665 - ..
610666 - On 121212 0941 re-test lab reported Glucose 111, sodium 139,
610667 - and potassium (K) 4.6, all within range, ref SDS 33 KK9M,
610668 - correcting errors noted by Doctor Egan during meeting at VA on
610669 - 121206 0900. ref SDS 32 6K4J
610670 -
610672 - ..
610673 - 3. Glucose 104.....74 - 118......... ref SDS A6 ZG5O
610674 -
610675 - Labcorp test today showing glucose 87 for range 65-99
610676 - significantly improves earlier Labcorp test showing glucose 99
610677 - reported on 150512. and has remained within VA range, per
610678 - above. ref SDS A2 ZG5O Current Glucose 87 decline correlates
610679 - with hiking 240 miles past 3 weeks, per below. ref SDS A2 GY6H
610681 - ..
610682 - Diabetes concern from reduced hiking due to metatarsalgia side
610683 - effects, causing weight to increase at times above 180; this
610684 - has subisded the past month, because hiking increased
610685 - significantly, as set out below. ref SDS A2 DC6L
610687 - ..
610688 - On 140814 VA Martinez lab reported HGBA1c 5.6 within range 4 -
610689 - 6, seems to indicate no evident exposure for diabetes.
610690 - ref SDS 77 H66G
610692 - ..
610693 - On 140514 0950 VA lab for HGBA1c 5.4 within range 4 - 6, seems
610694 - to indicate no evident exposure for diabetes. ref SDS 63 H66G
610695 -
610697 - ..
610698 - 4. Salt NA 144..................... ref SDS A6 WJ5H
610699 -
610700 - NA salt 147 rising above range seems anomolous with patient
610701 - history, including past 3 weeks hiking 240 miles, per below.
610702 - ref SDS A2 GY6H
610703 -
610705 - ..
610706 - 5. LDH 268 for range 0.0 - 225..... ref SDS A2 015M
610707 -
610708 - LDH increased further above range, and may reflect increased
610709 - hiking of 240 miles past 3 weeks, per below. ref SDS A2 GY6H
610711 - ..
610712 - Research indicates...
610713 -
610714 - http://get.smarter.com/qa/health/causes-elevated-ldh-levels-blood-bb5efae2447298f8?ad=semD&an=google_s&am=broad&o=33306
610715 -
610716 - ...elevation in LDH (lactic acid dehydrogenase) levels include
610717 - certain cancers, heart attack, blood flow deficiency, stroke or
610718 - other cerebrovascular accidents, hemolytic anemia or infectious
610719 - mononucleosis. Liver diseases, including hepatitis, may also
610720 - cause high levels of LDH. Low blood pressure, injuries to the
610721 - muscles, muscular dystrophy and tissue death are additional
610722 - causes, according to Healthline.
610724 - ..
610725 - Liver damage seems also associated with elevated bilirubi due to
610726 - statin side effects, per above. ref SDS A2 FX40
610727 -
610728 -
610729 -
610730 -
610731 -
610732 -
610733 -
6108 -
SUBJECTS
VA Lab Lipid Cholesterol 164 with Medication Hiking 1000 Miles Weigh
8103 -
810401 - ..
810402 - HDL 72 TG 72 Hike 13 Miles Past 2 Days Practically 0 Miles Past 2 Months
810403 -
810404 - Follow up ref SDS D1 IM9N, ref SDS D2 IM9N.
810405 -
810406 - Prior LIPID PANEL 120509 1108. ref SDS 26 IM9N
810407 - Prior LIPID PANEL 120831 1525. ref SDS 27 IM9N
810408 - Prior LIPID PANEL 130228 1140. ref SDS 36 IM9N
810409 - Prior LIPID PANEL 130529 0818. ref SDS 38 IM9N
810410 - Prior LIPID PANEL 131015 0724, ref SDS 40 IM9N
810411 - Prior LIPID PANEL Labcorp, 140201 1159, ref SDS 52 IM9N
810412 - Prior LIPID PANEL, 140203 1147, ref SDS 53 IM9N
810413 - Prior LIPID PANEL Labcorp, 140508 1149. ref SDS 60 IM9N
810414 - Prior LIPID PANEL, 140814 1530, ref SDS 70 IM9N
810415 - Prior LIPID PANEL Labcorp, 141021 1009. ref SDS 76 IM9N
810416 - Prior LIPID PANEL, 141021 1150, ref SDS 77 IM9N
810417 - Prior LIPID PANEL Labcorp, 141106 0630, ref SDS 79 IM9N
810418 - Prior LIPID PANEL Labcorp, 141201 0852, ref SDS 82 IM9N
810419 - Prior LIPID PANEL Labcorp, 150208 1438, ref SDS 85 IM9N
810420 - Prior LIPID PANEL VA Medical Center San Francisco, 150209 1012, ref SDS 86 IM9N
810421 - Prior LIPID PANEL Labcorp, 150512 1239, ref SDS 89 IM9N
810422 - Prior LIPID PANEL VA Clinic Martinez, 150512 1349, ref SDS 90 IM9N
810423 - Prior LIPID PANEL Labcorp, 150602 1300, ref SDS 91 IM9N
810424 - Prior LIPID PANEL VA Medical Center San Francisco, 150728 1146, ref SDS 93 IM9N
810425 - Prior LIPID PANEL Labcorp, 160131 1714, ref SDS A2 IM9N
810426 - Prior Lipid Panel VA Medical Center San Francisco, 160202 1220. ref SDS A4 IM9N
810427 - Prior LIPID PANEL Labcorp, 160401 1219, ref SDS A6 IM9N
810428 - Prior Lipid Panel VA Medical Center San Francisco, 160503 1130. ref SDS A7 IM9N
810429 - Prior LIPID PANEL Labcorp, 160717 1053, ref SDS B3 IM9N
810430 - Prior LIPID PANEL Labcorp, 161009 1320, ref SDS B4 IM9N
810431 - Prior Lipid Panel VA Medical Center San Francisco, 161011 1100. ref SDS B5 IM9N
810432 - Prior Lipid Panel VA Medical Center San Francisco, 170206 1100, ref SDS B8 IM9N,
810433 - Prior LIPID PANEL Labcorp, 170216 1634, ref SDS C1 IM9N
810434 - Prior Lipid Panel VA Medical Center San Francisco, 170412 0700, ref SDS C7 IM9N,
810435 -
810437 - ..
810438 - LIPID PANEL
810439 - ..
810440 - x x
810441 - Dates..........2017 04 12 0700 170216 1639 170206 1049 161011 1114 161009 1337 160717 1055 160503 1145 160401 1443 160202 1334 160131 1714 151027 1152 150728 1154 150602 1300 150512 1349 150512 1300 150209 150208 141201 141106 0714 141021 1148 141021 1021 140814 140514 140508 140203 140201 131015 130529
810442 - VAMCSF Labcorp VAMCSF VAMCSF Labcorp Labcorp VA Labcorp VA Labcorp VA VA Labcorp VA Labcorp VA Labcorp Labcorp Labcorp VA Labcorp VA VA Labcorp VA Labcorp VA VA VA Labcorp
810443 - NMR LipoProfile Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Results Units Range Range
810444 - LDL Particle Number
810445 - LDL P 1678 H 1619 H 1346 H 1379 H 699 1158 H 2537 H 709 656 997 H 1586 851 861 nmol/L Low < 1000
810446 - Moderate 1000 - 1299
810447 - Borderline High 1300 - 1599
810448 - High 1600 - 2000
810449 - Very High > 2000
810451 - ..
810452 - Lipids
810453 - CHOL 184 242 H 196 231 245 229 196 197 177 183 315 153 199 H 299 H 282 H 161 162 157 137 159 157 161 (a) 164 162 160 156 321 H 307 mg/dL 100 - 240 < 200
810454 - (b) 169
810455 - TRIGLYC 67 103 72 66 98 70 55 88 61 61 59 54 77 103 108 50 66 73 85 65 80 72 (a) 58 59 47 68 109 85 mg/dL 10 - 190 < 150
810456 - (b) 59
810457 - HDL-C 54 72 61 62 65 67 57 56 69 73 60 65 69 58 56 70 66 63 53 57 55 55 (a) 66 67 58 61 50 50 mg/dL Ref: >=35 >= 4 0
810459 - ..
810460 - LDL-C 117 149 H 121 156 H 160 148 128 123 96 98 243 78 115 H 220 H 204 H 81 83 79 67 90 86 92 (a) 87 83 93 81 249 H 240 mg/dL Ref: <=131 < 160
810461 - (b) 90
810462 - ** LDL Dir 93 mg/dL 0 - 130
810463 - TRIG NF mg/dL Ref: <=150
810465 - ..
810466 - TC/HDL ratio 3.2 3.7 3.8 3.4 3.4 3.5 2.6 2.5 5.3 2.49 2.49 2.58 2.79 2.85 2.93 2.48 2.42 2.76 2.56
810467 - TG/HDL ratio 1.2 1.1 1.5 1.0 1.0 1.6 0.9 0.8 1.0 2.49 2.49 2.58 2.79 2.85 2.93 2.48 2.42 2.76 2.56
810469 - ..
810470 - LDL and HDL Particles
810471 - HDL-P (Total) 42.5 40.4 39.4 33.9 41.9 42.3 34.3 39.5 38.9 35.2 36.4 38.1 31.4 umol/L >= 30.5
810472 - Small LDL-P 843 H 543 436 636 H 176 417 1141 H 153 310 387 H 1277.0 < 90.0 < 90.0 umol/L <=527.0
810473 - LDL Size 20.6 21.2 21.2 20.6 20.9 20.9 20.8 21.0 20.4 Low 20.8 L 19.7 21.2 21.3 nm > 20.5
810474 -
810476 - ..
810477 - Article explains HDL-P...
810478 -
810479 - Clinical Chemestry
810480 -
810481 - HDL-C vs HDL-P: How Changing One Letter Could Make a
810482 - Difference in Understanding the Role of High-Density
810483 - Lipoprotein in Disease
810484 -
810485 - http://clinchem.aaccjnls.org/content/60/11/e1
810487 - ..
810488 - HDL-P can be measured by NMR or by ion mobility (IM)
810489 - spectrometry.
810491 - ..
810492 - Most people measure HDL-P 32 - 34 using NMR methods, so 42.4
810493 - indicates high concentration.
810495 - ..
810496 - Most people measure HDL-P 5 - 6 using IM methods.
810497 -
810498 -
810500 - ..
810501 - --------------------------------------------------------
810502 - ** INTERPRETATIVE INFORMATION**
810503 - PARTICLE CONCENTRATION AND SIZE
810505 - ..
810506 - LDL AND HDL PARTICLES Percentile in Reference Population
810507 - HDL-P (total) High 75th 50th 25th Low
810508 - >34.9 34.9 30.5 26.7 <25.7
810509 - ..
810510 - Small LDL-P Low 25th 50th 75th High
810511 - <117 117 527 839 >839
810513 - ..
810514 - LDL Size <- Large (Pattern A)-> <- (Pattern B) ->
810515 - 23.0 20.6 20.5 19.0
810516 -
810518 - ..
810519 - Comment:
810520 -
810521 - Small LDL-P and LDL Size are associated with CVD risk, but
810522 - not after LDL-P is taken into account.
810524 - ..
810525 - These assays were developed and their performance
810526 - characteristics determined by LipoScience. These assays
810527 - have not been cleared by the US Food and Drug
810528 - Administration. The clinical utility of these laboratory
810529 - values have not been fully established.
810531 - ..
810532 - Insulin Resistance Score x x
810533 - LP-IR Score <25 < 25 < 25 < 25 45 < 25 H 46.0 < 25.0 < 25.0 <= 45.
810534 -
810536 - ..
810537 - INSULIN RESISTANCE MARKER
810538 -
810539 - <--Insulin Sensitive Insulin Resistant-->
810540 - Percentile in Reference Population
810541 - Insulin Resistance Score
810542 - LP-IR Score Low 25th 50th 75th High
810543 - <27 27 45 63 >63
810544 -
810546 - ..
810547 - Comments...
810548 -
810549 - LP-IR Score is inaccurate if patient is non-fasting. The
810550 - LP-IR score is a laboratory developed index that has been
810551 - associated with insulin resistance and diabetes risk and
810552 - should be used as one component of a physician's clinical
810553 - assessment. The LP-IR score listed above has not been
810554 - cleared by the US Food and Drug Administration.
810555 -
810556 - ========================================
810558 - ..
810559 - Final Report Labcorp NMR Lipid Panel
810561 - ..
810562 - Date Issued: 02/02/16 1133 ET
810564 - ..
810565 - This document contains private and confidential health
810566 - information protected by state and federal law.
810567 - If you have received this document in error, please call
810568 - 858-668-3700
810569 -
810570 - 1995-2014 Laboratory Corporation of America® Holdings
810571 - All Rights Reserved - Enterprise Report Version 1.00
810573 - ..
810574 - 02 BN William F Hancock, MD
810575 - Labcorp Burlington
810576 - 1447 York Court, Burlington, NC 27215-3361
810577 - 877 547 6837
810578 - 800-762-4344 Lab: 858-668-3700
810579 - Bianca
810580 - duranb3@labcorp.com
810582 - ..
810583 - For inquiries, the physician may contact Branch: 800 762 4344
810584 - Lab: 858 668 3700
810586 - ..
810587 - Prior labs contact for NMR Lipids...
810588 -
810589 - 02 BN Deanna Franke, PhD
810590 - Liposcience Inc
810591 - 2500 Sumner Blvd, Raleigh, NC 27616-3235
810592 - 877 547 6837
810593 - 800-762-4344 Lab: 858-668-3700
810594 - customer.service@liposcience.com
810595 -
810596 -
810598 - ..
810599 - Lipid History Trend Analysis
810600 -
810601 - Follow up ref SDS D1 W25L, ref SDS D2 W25L.
810602 -
810603 - There are 3 tests for cholesterol performed for an examination cycle:
810604 - (1) VA, (2) Liposcience NMR lipids, and (3) Labcorp lipids.
810605 - Confidence in lab results is high when these labs are in close
810606 - proximity...
810607 - Small LDL LP-IR
810608 - Collection DT CHOL TRIGL HDL LDL-C LDL-P HDL-P LDL-P SIZE SCORE LDL-D
810609 - 04/12/2017 07:00 184 67 54 117 ........................................... ref SDS C7 U45J
810610 - 02/16/2017 16:39 242 H 103 72 149 H .1678....42.5...943...20.6....< 25....... ref SDS C1 U45J
810611 - 02/06/2017 10:49 196 72 61 121 ........................................... ref SDS B8 U45J
810612 - 10/11/2016 11:14 231 66 62 156 ........................................... ref SDS B5 U45J
810613 - 10/09/2016 13:37 245 98 65 160 ...1619....40.4...543...21.2....< 25....... ref SDS B4 U45J
810614 - 07/17/2016 10:55 229 70 67 148 ...1346....39.4...436...21.2....< 25....... ref SDS B3 U45J
810615 - 06/18/2016 00:54 230 66 63 153 ........................................... ref SDS A9 U45J
810616 - 05/03/2016 11:45 196 55 57 128 ........................................... ref SDS A7 U45J
810617 - 04/01/2016 14:43 197 88 56 123 ...1379....33.9...636...20.6......27....... ref SDS A6 U45J
810618 - 02/02/2016 13:34 177 61 69 96 ........................................... ref SDS A4 U45J
810619 - 01/31/2016 17:14 183 61 73 98 ....699....41.9...176...20.9....< 25....... ref SDS A3 U45J
810620 - 10/27/2015 13:49 315 H 59 60 243 H ......................................... ref SDS 97 5C7M
810621 - 07/28/2015 11:54 153 54 65 78 ........................................... ref SDS 94 U45J
810622 - rets 06/02/2015 13:00 199 H 77 69 115 H .1158....42.3...417...20.9....< 25....... ref SDS 92 U45J
810623 - 05/12/2015 13:49 299 H 103 58 220 H ......................................... ref SDS 91 5C7M
810624 - erro 05/12/2015 13:00 ?? 282 H 108 56 204 H .2537....34.3..1141...20.8......45....... ref SDS 90 BE6O
810625 - 02/09/2015 11:21 161 50 70 81 ......................................... ref SDS 87 BE6O
810626 - 02/08/2015 14:52 162 66 66 83 ..709....39.5...153...21.0....< 25....... ref SDS 86 BE6O
810627 - 12/01/2014 08:40 157 73 63 79 ..656....38.9...310...20.4....< 25....... ref SDS 83 BE6O
810628 - rets 11/06/2014 07:14 137 85 53 67 ..997....35.2...387...20.8......30....... ref SDS 80 BE6O
810629 - erro 10/21/2014 10:21 157 80 55 86 .1586....36.4..1277...19.7......46....... ref SDS 77 BE6O
810630 - 10/21/2014 11:48 159 65 57 90 ......................................... ref SDS 78 BE6O
810631 - 08/14/2014 15:28 161 72 55 92 ......................................... ref SDS 70 BE6O
810632 - 05/14/2014 10:16 164 58 66 87 .................................... 93.. ref SDS 63 BE6O
810633 - 05/08/2014 11:49 162 59 67 83 ..851....38.1...<90...21.2....< 25 ..... ref SDS 60 U45J
810634 - 02/03/2014 12:28 160 47 58 93 ......................................... ref SDS 53 BE6O
810635 - 02/01/2014 12:31 156 68 61 81 ..861....31.4...<90...21.3....< 25....... ref SDS 52 HW5M
810636 - 10/15/2013 08:25 321 H 109 50 249 H ......................................... ref SDS 40 BE6O
810637 - 05/29/2013 08:18 307 H 85 50 240 H ......................................... ref SDS 38 BE6O
810638 - 02/28/2013 08:39 310 H 73 47 248 H ......................................... ref SDS 36 BE6O
810639 - 11/30/2012 10:01 173 53 57 105 ......................................... ref SDS 31 BE6O
810640 - 08/31/2012 15:25 176 94 47 110 ......................................... ref SDS 27 U89N
810641 - 05/09/2012 11:24 158 76 49 94 ......................................... ref SDS 26 U89N
810642 - 02/09/2012 11:18 285 82 41 228 H ......................................... ref SDS 22 2A4G
810643 - 11/17/2011 14:27 260 84 43 200 H ......................................... ref SDS 20 2A4G
810644 - 07/27/2011 12:58 163 81 45 102 ......................................... ref SDS 16 E19L
810645 - 12/07/2010 09:17 151 41 47 96 ......................................... ref SDS 15 E19L
810646 - 07/21/2010 08:54 261 H 87 35 L 209 H ......................................... ref SDS 11 E19L
810647 - 06/10/2010 10:33 217 H 83 36 L 164 H ......................................... ref SDS 10 QV4F
810648 - 12/14/2009 11:10 241 H 136 44 170 H ......................................... 100928 0706, ref SDS 12 VW6J
810649 - 08/13/2009 15:09 233 H 118 30 L 179 H ......................................... 100610 1046, ref SDS 10 U45G
810650 - 06/16/2006 10:59 238 H 68 32 L 192 H ......................................... 091002 0900, ref SDS 6 LJ5H
810651 -
810652 -
810653 -
810654 - * Lab at VA San Francisco Medical Center reported on 100928 0706.
810655 - ref SDS 12 VW6J
810657 - ..
810658 - Research on cholesterol reported on 091002 0900. ref SDS 6 2F8K
810660 - ..
810661 - On 131125 0005 research found ezetimibe (zetia) mg added to
810662 - Atorvastatin 20 mg yielded after 6 weeks significantly greater changes
810663 - to lipids than taking Atorvastatin in higher doses, e.g., 20 or 40 mg.
810664 - ref SDS 46 CO56
810666 - ..
810667 - On 131125 0005 research found discordance LDL-P low and LDL-C high
810668 - lipid panel HDL 65 TG 77 healthy patient profile with LDL 246.
810669 - ref SDS 46 MN98 Discordance with LDL-P low and LDL-C high is lowest
810670 - risk for CVD, arterialsclorosis. ref SDS 46 FI3G
810672 - ..
810673 - Analysis....
810674 -
810675 - 1. HDL 73 and Triglycerides 61 (Labcorp) approximately 20% better
810676 - than Labcorp HDL 60 and TG 66 reported for prior lab at the VA
810677 - on 151027 1150, ref SDS 96 5C7M, show effects of endurance
810678 - exercise hiking 240 miles the past 3 weeks. As well, hiking
810679 - 122 miles the past week, and 26 miles on 160131, could be
810680 - significant factors raising HDL and lowering TG, per below.
810681 - ref SDS A6 GY6H
810683 - ..
810684 - HDL 73 increased HDL 70 a year ago - at that time primary care
810685 - Doctor Rao seemed to indicate it would be physically impossible
810686 - to increase HDL above 70, reported during meeting at the VA
810687 - Medical Center in San Francisco on 150213 0830. ref SDS 87 ZM37
810689 - ..
810690 - Hiking 30 miles in 2 days should have increased HDL 73 to HDL
810691 - 75, 76 for the test today, based on patient history, rather
810692 - than lowered HDL 73 to 69, reported by the VA today.
810694 - ..
810695 - 2. LDL-P 699 is best NMR lipid panel in over a year, ref SDS A2
810696 - BE6O, since LDL-P 656 on 141201 0850. ref SDS 82 U45J
810698 - ..
810699 - 3. The test today shows HDL and TG are responsive to high levels
810700 - of physical activity hiking 240 miles the past 2 weeks, and 122
810701 - miles the past week, shown below. ref SDS A2 GY6H
810703 - ..
810704 - 4. Research indicates healthiest cardiovascular condition occurs
810705 - with lowest risk for CVD, when lipids are discordant, with
810706 - LDL-P low and LDL-C high. However, greatest risk for CVD is
810707 - LDL-P high and LDL-C low, shown in the record on 131125 0005.
810708 - ref SDS 46 FI3G
810710 - ..
810711 - 5. VA published goal LDL-C <= 131; Labcorp published goal LCL-C <
810712 - 100. ref SDS 63 5C7M New AHA guidelines show LDL-C < 190,
810713 - reported on 131112 1422. ref SDS 44 HT87
810715 - ..
810716 - 6. VA lowering goal to HDL > 35, per above, ref SDS 85 5C7M, from >
810717 - 40 seems conflicting with patient history of CABG +4 on 091022
810718 - 0700. ref SDS 7 PQWU Since HDL 30 was found at that time (see
810719 - Lipid history below, ref SDS 63 W25L, setting the bar at HDL 35
810720 - has little tolerance for genetic variation to avoid and repair
810721 - endothelium lesions causing atheriosclerotic plaque.
810723 - ..
810724 - 7. Resting heart rate getting up in the mornings has increased
810725 - above 50. Blood pressure averages about 127 68; however,
810726 - systolic often drops below 120, and diastolic often falls below
810727 - 60. After 11 mile hikes blood pressure drops to about 105 55.
810728 - Systolic on occassion falls below 90. Dystalic has fallen
810729 - below 50 - e.g., see Saturday, 141018, reported in case study
810730 - on 120101 0900, ref SDS 21 V83O Heart rate now recovers well
810731 - after strenuous exercise, often falling back below 60 within 20
810732 - minutes or so.
810734 - ..
810735 - 8. Cholesterol................... 177................ ref SDS A6 U45J
810736 -
810737 - TC 183 fell from 350, reflects resuming statin treatments with
810738 - Atorvastatin 10 mg and Ezetimibe 10 mg on 151028, shown in case
810739 - study on 140101 0600. ref SDS 48 UH6N
810741 - ..
810742 - LDL-C......................... 98................ ref SDS A2 U45J
810744 - ..
810745 - LDL-c 98 fell from 240, reflects resuming statin treatments
810746 - with Atorvastatin 10 mg and Ezetimibe 10 mg on 151028, shown in
810747 - case study on 140101 0600. ref SDS 48 UH6N LDL-C is calculated
810748 - and so can be "assumed" from the Friedwald equation...
810749 - Cholesterol - HDL - TG/5 (reported on 140213 0830. ref SDS 56
810750 - Z37L).
810752 - ..
810753 - 9. Improved HDL and TG lipids reflect...
810755 - ..
810756 - a. Physical activity prescribed by the VA on 140213,
810757 - ref SDS 56 E34O, has recovered after a pause of 5 months to
810758 - recover from side effects, and now continues from prior
810759 - levels hiking 300+ miles per month, and supplemented with
810760 - 750 ml orange juice per day (explained below, ref SDS 86
810761 - LO4J)...
810763 - ..
810764 - Mileage 2015 and Beginning 2016 Since Prior Lab
810765 -
810766 - Follow up ref SDS D1 ZY7M, ref SDS D2 ZY7M.
810767 -
810768 - 150201....Jan................... 242 3687 ...... ref SDS 48 TSYW
810769 - 150302....Feb................... 256 3941 ...... ref SDS 48 VYVP
810770 - 150329....Mar................... 189 2941 ...... ref SDS 48 WUTU
810771 - 150503....Apr................... 240 3698 ...... ref SDS 48 XVVR
810772 - 150531....May................... 230 3485 ...... ref SDS 48 PPXS
810773 - 150628....June.................. 233 3571 ...... ref SDS 48 QZ6J
810774 - 150802....July.................. 230 3559 ...... ref SDS 48 RSVY
810775 - 150830....August................ 142 2241 ...... ref SDS 48 SVPP
810776 - 150927....September............. 212 3658 ...... ref SDS 48 TVQP
810777 - 151101....October............... 323 5337 ...... ref SDS 48 YN4J
810778 - 151129....November.............. 152 2461 ...... ref SDS 48 WRYV
810779 - 160103....December.............. 73 1158 ...... ref SDS 48 LX6I
810781 - ..
810782 - Mileage January 2016
810783 -
810784 - Follow up ref SDS D1 GY6H, ref SDS D2 GY6H.
810785 -
810786 - 160110........................ 0 0 ...... ref SDS 48 324G
810787 - 160117........................ 47 735 ...... ref SDS 48 KB6G
810788 - 160122........................ 60 952 ...... ref SDS 48 SV4K
810789 - 160131........................ 122 1925 ...... ref SDS 48 143K
810790 - ----- -----
810791 - 240 3784
810793 - ..
810794 - b. Weight increased to 182 on date of lab 160202 (see case
810795 - study on 140101 0600, ref SDS 48 015L Hiking lowers weight
810796 - more in the summer with higher temperatures that consume
810797 - calories and triglycerides. Extended endurance exercise
810798 - reduces time and interest in eating. Lower weight tends to
810799 - reduce tryglycerides, which tends to increase LDL-P size =
810800 - 21.0, reported on 150208 1438. ref SDS 85 5C86 ref SDS 85
810801 - 5C86 Evidence indicates weight is highly sensitive to
810802 - eating and exercise, and directly correlates to CVD risk.
810804 - ..
810805 - c. Week ending 160131, hiked 122 miles 2nd most in patient
810806 - history for 1 week, including 10 days in a row hiking 15
810807 - miles per day. ref SDS 48 143K
810809 - ..
810810 - d. Low-carbohydrate diet works best in this case with
810811 - elevated physical activity, because exhaustion from hiking
810812 - reduces desire/energy for eating.
810814 - ..
810815 - e. Chia seeds added to diet on 131125, reported in case study
810816 - on 120101 0900, ref SDS 21 746M, and recommended for
810817 - sustained energy hiking by Karen at VA on 131121 0930.
810818 - ref SDS 45 NQ37
810820 - ..
810821 - f. CoQ10 (Ubiquinol) added to diet for energy to recover from
810822 - loss of CoQ10 due to age and statin medications, started on
810823 - 151213, shown in case study on 140101 0600. ref SDS 48 MU6G
810825 - ..
810826 - g. Orange juice may have increased slightly this cycle, likely
810827 - contributing to HDL 70 rising 27%, ref SDS 86 U45J, from HDL
810828 - 55 on 141021, and supplementing increased physical
810829 - activity, and as explained in the prior lab analysis on
810830 - 140514 0950. ref SDS 63 LO4J
810832 - ..
810833 - h. Atorvastatin 10 mg with Ezetimibe 10 begun on 131230,
810834 - reported in case study on 120101, ref SDS 21 6A6H, and
810835 - continued through current cycle.
810837 - ..
810838 - Cholesterol 161 remained comparable to prior level 157 on
810839 - 141021, per above, ref SDS 86 5C7M, indicating minimal
810840 - effects pausing Atorvastatin 10 mg and Ezetimibe 10 mg for
810841 - 12 days due to delays in refill processing, cited in the
810842 - letter to the VA on 141218 0359. ref SDS 83 5N3O
810844 - ..
810845 - Research studies report Atorvastatin 10 mg + Ezetimibe 10
810846 - mg achieves LDL < 70, and favorably changes triglycerides
810847 - and HDL by 5%, reported on 131125 0005. ref SDS 46 CO45
810848 - While low LDL < 70 conflicts with goal of "discordance"
810849 - that lowers health risk for arterialsclorosis and CVD when
810850 - LDL-P low and LDL-C high, shown in research on 131125 0005,
810851 - ref SDS 46 FI3G, even "concordant" results today are good
810852 - news.
810853 -
810854 -
810856 - ..
810857 - Statins Reduce CCTA Found Atherosclerosis Regressed 6 Years After CABG
810858 - CCTA Found Atherosclerosis Regressed 6 Years After CABG Reduce Statins
810859 - Coronary CTA or IVUS Test Athereosclerosis Plaque 6 Years After CABG
810860 - Athereosclerosis Plaque 6 Years After CABG Coronary CTA or IVUS Test
810861 -
810862 - Follow up ref SDS D1 QA4M, ref SDS D2 QA4M.
810863 -
810864 - On 131125 0005 research further found radiology imaging tests can
810865 - evaluate level of plaque build up resulting from elevated cholesterol.
810866 - ref SDS 46 N73K Radiology imaging technologies are Coronary CT
810867 - angiography - CTA - and Intravascular ultrasound - IVUS. ref SDS 46
810868 - KZ8O
810870 - ..
810871 - Lipid history past few years ith HDL >= 60 and Triglycerides < 80
810872 - ref SDS A2 W25L, indicates body chemestry causes rapid regression of
810873 - atherosclerosis plaque, cited in research on 131125 0005. ref SDS 46
810874 - RA7K Research indicates that favorable lipid profile, weight loss,
810875 - and production of EPC in the bone marrow, all stimulated by exercise,
810876 - drives regression of plaque. ref SDS 46 XY7L
810878 - ..
810879 - Medication diet, and exercise interventions the past 4 years, since
810880 - CABG x4 on 091022 0700, ref SDS 7 PQWU, supported radiology testing
810881 - for regression of atherosclerosis plaque, which previously required
810882 - major surgery to fix.
810884 - ..
810885 - CCTA testing was supported by patient history using CT radiology
810886 - imaging to assess regression of esophageal bubble after 4 years of
810887 - medical interventions, reported favorable by Doctor Stewart, Chief
810888 - General Surgery at VA on 130122 1330. ref SDS 34 03H6 CT radiology
810889 - with calcium score is commonly used to assess response to treatment
810890 - for regression of athersclerosis, reported during the meeting at the
810891 - VA on 140519 0800. ref SDS 65 OF7N
810893 - ..
810894 - On 151019 CCTA test was performed at VA Medical Center in San
810895 - Francisco. ref SDS 94 NV5I Initial report found all bypass grafts are
810896 - patent. ref SDS 94 JW8O
810898 - ..
810899 - On 151203 1014 meeting with Doctor Elicker in Radiology Department
810900 - seemed to clarify that he read the CCTA scan file performed on 151019,
810901 - and found no evidence of blockages of any amount anywhere in the
810902 - active circulatory system which was covered by the scan. ref SDS 97
810903 - SZ5F
810905 - ..
810906 - On 160104 0855 Doctor Jha, attending physician for this CCTA imaging
810907 - study, advised that standard of practice for radiology reporting is to
810908 - present any and all blockages of any kind observable in CCTA scan
810909 - imaging; so, in this case, since none are reported, the CCTA test on
810910 - 151019, ref SDS 94 JW8O, can correctely be interpretted to mean there
810911 - are no blockages, plaques, stenosis of any kind evident from the scan
810912 - file record. ref SDS 98 AA64
810914 - ..
810915 - On 160113 2234 received letter from Doctor Jha saying the radiology
810916 - faculty approved issuing an addendum. ref SDS 90 A85F
810917 -
810918 - No significant calcified plaque is seen in the bypass grafts.
810919 - All the bypass grafts are opacified with contrast without
810920 - evidence for filling defect or wall calcifications.
810922 - ..
810923 - No calcification is seen in the aortic wall in the visualized
810924 - portions of the thoracic aorta. No ostial calcifications at the
810925 - origins of great vessels from the aortic arch.
810927 - ..
810928 - This seems another way of saying in the written medical record that
810929 - CCTA testing found no evidence of atherosclerotic plaque of any kind
810930 - or amount visualized in the CCTA scan.
810932 - ..
810933 - On 160114 0022 letter commends Doctor Jha and faculty colleagues at
810934 - UCSF for good faith review to clarify CCTA on 151019, that
810935 - demonstrates CCTA evaluating response to treatment (hiking 10K miles
810936 - raising HDL 30 to 70) for regressing atherosclerosis to 0. ref SDS A1
810937 - N760
810939 - ..
810940 - This record together with continued elevated HDL 73 supports reducing
810941 - statin medications in order to reduce side effects.
810942 -
810943 -
810944 -
810945 -
810946 -
8110 -
SUBJECTS
Default Null Subject Account for Blank Record
8203 -
820401 - ..
820402 - Coronary Adverse Event Risk
820403 -
820404 - Follow up ref SDS D1 126H, ref SDS D2 126H.
820405 -
820406 - x
820407 - Dates......... 2016 10 11 1114 160503 1145
820408 - VAMCSF VA VA
820409 - Blood Results Results Units Range
820410 - CRP-HS 3.9 20.6 mg/L 0.2 - 7.5
820412 - ..
820413 - For assessment of risk for cardiovascular disease in adults.
820414 - The CDC and AHA recommnd the following guidelines based on two
820415 - test results, two weeks apart in metabolically stable patients.
820417 - ..
820418 - Cardiovascular Disease Risk CRP-HS mg/L
820419 - Low......................................... < 1.0
820420 - Average..................................... 1.0 - 3.0
820421 - High........................................ 3.0 - 10.0
820422 - Indeterminate............................... > 10
820424 - ..
820425 - If CRP-HS level is >10 mg/L, the patient should be evaluated
820426 - for possible sources of infection or inflammation. Repeat
820427 - CRP-HS may also be appropriate.
820428 -
820429 -
820430 -
820431 -
820432 -
820433 -
820434 -
820435 -
820436 -
820437 -
820438 -
8205 -
SUBJECTS
VA Lab Cardiac Enzymnes Creatine Kinase CK also CPK Creatine Phospho
9003 -
900401 - ..
900402 - Myopathy Muscle Pain Side Effects Simvistatin Decline
900403 -
900404 - Follow up ref SDS D1 D26G, ref SDS D2 D26G.
900405 -
900406 - Prior Cardiac Enzymes Profile on 120209 1118. ref SDS 22 D26G
900407 - Prior Cardiac Enzymes Profile on 120509 1108. ref SDS 26 D26G
900408 - Prior Cardiac Enzymes, 131015 0724, ref SDS 40 D26G
900409 - Prior Cardiac Enzymes Profile VA on 140203 1147. ref SDS 53 NX6G
900411 - ..
900412 - This test not performed by Labcorp with blood draw earlier today on
900413 - 150512, nor by the VA with blood draw today. Most recent testing
900414 - showed...
900415 -
900416 - CARDIAC ENZYMES
900417 -
900418 - Dates 2014 05 14 1016 140508 140203 131015 120509
900419 - VA Labcorp VA VA VA
900420 - PLASMA Results Results Results Results Results Units Range
900421 - CPK (CK) 192 149 110 152 U/L 30 - 235
900422 - TRPONIN ng/ml 0 - 0.07
900423 - CK-MB ng/ml 0.6 - 3.5
900424 - MYOGLOB ng/ml 20 - 82
900426 - ..
900427 - a. CPK/CK test not performed by Labcorp
900429 - ..
900430 - b. SLIGHTLY ICTERIC SPECIMEN /HN
900432 - ..
900433 - c. Ordering Provider: Diana Alba
900434 - Report Released..: May 14, 2014@11:29
900435 - Reporting Lab....: SAN FRANCISCO VAMC [CLIA# 05D0988226]
900436 - 4150 CLEMENT STREET
900437 - SAN FRANCISCO, CA 94121-1545
900438 - Performing Lab...: SAN FRANCISCO VAMC [CLIA# 05D0988226]
900440 - ..
900441 - CKP and CK are the same thing - creatine phosphokinase (CPK) also
900442 - called creatine kinase (CK).
900443 -
900444 - http://www.scai.org/SecondsCount/Resources/Detail.aspx?cid=ed385473-d4e8-491e-9ce0-a7c984fe6f8e#.U3b_BfldWi8
900446 - ..
900447 - Research on 111013 explains Creatine Kinase CK, relates to muscle
900448 - disorders caused by cholesterol medications with statins. 111013 1404,
900449 - ref SDS 19 J54K
900451 - ..
900452 - CK lab may align with reduced side effects of muscle pain in left
900453 - shoulder.
900454 -
900455 -
900456 -
900457 -
900458 -
900459 -
9005 -
SUBJECTS
HGBA1C 5.4 Range 4.0-6.0 Diabetes Negative Laboratory Blood Test Cro
A703 -
A70401 - ..
A70402 - HGBA1c Diabetes Blood Test A1c
A70403 - A1c Diabetes Blood Test HGBA1c
A70404 - Diabetes HGBA1c A1c Blood Test
A70405 -
A70406 - Follow up ref SDS D1 9F4O, ref SDS D2 9F4O.
A70407 -
A70408 - Prior HGBA1c Profile on 100721 0800. ref SDS 11 IL4N
A70409 - Prior HGBA1c Profile on 101207 0906. ref SDS 15 IL4N
A70410 - Prior HGBA1c Profile on 131015 0724. ref SDS 40 9F4O
A70411 - Prior HGBA1c Profile on 140203 1147. ref SDS 53 9F4O
A70413 - ..
A70414 - This test not performed by Labcorp with blood draw earlier today on
A70415 - 150212, nor by the VA with blood draw today. Most recent testing
A70416 - showed...
A70418 - ..
A70419 - Endocrine IV - HGBA1c - A1c
A70420 -
A70421 - Dates..........2016 10 11 1114 140814 1528 140514 140508 140203 131015 101207
A70422 - VA VA VA Labcorp VA VA VA
A70423 - BLOOD Results Results Results Results Results Results Results Units Range
A70424 - HGBA1c 5.7 5.6 5.4 5.5 5.5 5.7 % 4.0 - 6.0
A70425 - eAG 114 111 111 mg/dL 74.0 - 118
A70427 - ..
A70428 - This test for diabetes was ordered by Doctor Abrams during a meeting
A70429 - at the San Francisco VA Medical Center on 130227 0930. ref SDS 35 8T5L
A70430 - However, it is not reported for the lab performed the next day on
A70431 - 130228 1140, ref SDS 36 RP4N, nor in the follow up lab 3 months later
A70432 - on 130529 0818. ref SDS 38 RP4N
A70434 - ..
A70435 - HGBA1c was performed previously on 101207 0906, ref SDS 15 IL4N, and 5
A70436 - months earlier on 100721 0800. ref SDS 11 IL4N
A70438 - ..
A70439 - Labcorp test showing LP-IR Score < 25, ref SDS B5 TU6L, indicating risk
A70440 - of diabetes declined.
A70441 -
A70442 -
A70443 -
A70444 -
A70445 -
A705 -
SUBJECTS
Default Null Subject Account for Blank Record
A803 -
A80401 - ..
A80402 - Prostate Evaluation PSA Tumor Markers
A80403 -
A80404 - Follow up ref SDS D1 GM9G, ref SDS D2 GM9G.
A80405 -
A80406 - Prior PSA PANEL VA Clinic Martinez, 100721 0800, ref SDS 11 ER6N
A80407 - Prior PSA PANEL VA Clinic Martinez, 150512 1330, ref SDS 90 GM9G
A80408 -
A80410 - ..
A80411 - PSA Prostate Specific Ag
A80412 -
A80413 - Follow up ref SDS D1 1M9N, ref SDS D2 1M9N.
A80414 -
A80415 - Dates..........2015 05 12 1349 100721
A80416 - VA VA VA
A80417 - Serum Results Results Units Range
A80418 - AFP TM Not done ng/mL 0.0 - 8.0
A80419 - CEA Not done ng/mL 0.0 - 3.0
A80420 - PSA (Prostate) 2.18 1.25 ng/mL 0.0 - 4.0
A80421 - CA 125 Not done Units/mL 0.0 - 34.0
A80422 - CA 15-3 Not done Units/mL 0.0 - 25.0
A80423 - CA 19-9 Not done Units/mL 0.0 - 37.0
A80424 -
A80426 - ..
A80427 - Comments...
A80428 -
A80429 - a. Test Ordered by Doctor Harkesh Sandhu
A80430 - Performed at...
A80431 - MARTINEZ CBOC 150 MUIR ROAD
A80432 - MARTINEZ, CA 94553-4668
A80433 -
A80434 -
A80435 -
A805 -
SUBJECTS
Default Null Subject Account for Blank Record
A903 -
A90401 - ..
A90402 - Thyroid Stimulating Hormone
A90403 -
A90404 - Follow up ref SDS D1 PO6I, ref SDS D2 PO6I.
A90406 - ..
A90407 - Prior Thyroid PANEL VA Clinic Martinez, 150512 1330, ref SDS 90 PO6I
A90408 -
A90409 -
A90410 - Dates..........2015 05 12 1349
A90411 - VA VA
A90412 - Serum Results Units Range
A90413 - * THYROTROPIN 1.65 uIUnits/mL 0.34 - 5.60
A90414 -
A90416 - ..
A90417 - Seems to be new lab panel.
A90418 -
A90419 - Comments...
A90420 -
A90421 - a. Test Ordered by Doctor Harkesh Sandhu
A90422 - Performed at...
A90423 - MARTINEZ CBOC 150 MUIR ROAD
A90424 - MARTINEZ, CA 94553-4668
A90425 -
A90426 -
A90427 -
A90428 -
A90429 -
A90430 -
A90431 -
A90432 -
A90433 -
A90434 -
A90435 -
A90436 -
A90437 -
A90438 -
A905 -